top of page
< Back

Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia

Mattina, A.; Rosenbaum, D.; Bittar, R.; Bonnefont-Rousselot, D.; Noto, D.; Averna, M.; Bruckert, E.; Giral, P.

Date Published:

Publication:

DOI:

URL:

PMID:

Extra Links:

2018

10.1016/j.numecd.2018.01.012

PMID: 29525223

Abstract:

BACKGROUND AND AIM: Lipoprotein-associated phospholipase A2 (Lp-PLA2) plays a key role in atherosclerosis development. It is considered a marker of increased risk of cardiovascular disease (CVD) and plaque vulnerability. Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated plasma levels of low-density lipoprotein cholesterol and a higher prevalence of early CVD. Our aim was to evaluate the differences in Lp-PLA2 activity in a population of hypercholesterolemic patients with and without definite FH. METHODS AND RESULTS: Hypercholesterolemic patients were consecutively recruited. Definite FH was defined according to Dutch Lipid Clinic Network criteria ≥8. All patients underwent routine clinical examination and biological assessments and Lp-PLA2 activity was measured in blood samples. Among 469 patients, 118 had a definite diagnosis of FH. Lp-PLA2 activity was significantly higher in definite FH patients compared to non-definite FH patients (206.5 ± 54.5 vs. 180.8 ± 48.4 nmol/min/mL, p 

Automatic Tags

  • Facebook
  • Twitter
  • Instagram
  • Reddit's r/Ketoscience
bottom of page